Clinical Trial Update: Study of DONQ52 in Active Celiac Disease [Phase 2]

View source ↗

Summary

A Phase 2 study of DONQ52 for active celiac disease is currently recruiting, indicating early clinical investigation of this investigational therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• DONQ52

Snippet

Sponsor: Chugai Pharmaceutical | Conditions: Celiac Disease | Phase 2 | Status: RECRUITING